Zacks Investment Research
03 Aug 2026, 23:46 UTC · 15w ago
Diversified Healthcare (DHC) Q2 FFO Top Estimates
Impact · against what's priced in
DHC's Q2 results show an FFO beat of 14.29% and significant year-over-year growth, though this is tempered by a slight revenue miss and a year-over-year decline in top-line performance. While the operational efficiency is positive, the revenue trend suggests a possible slowdown in growth.
- DHC+0.20
No priced-in read yet
- In context
DHC beat FFO estimates by 14.29% ($0.16 vs $0.14) and showed strong year-over-year growth from $0.08, although revenues of $365.39 million missed estimates and declined from $382.71 million a year ago.
Read from the article alone

Top 2 movers · tap to explore




